|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Technical Developments |
1 From the Departments of Radiology (C.J.C.C.), Oncology (C.E.C.), Surgery (A.D.P.), and Engineering (G.M.T., A.H.G., R.W.P.), Cambridge University, Hills Road, Cambridge CB22QQ, England; and Department of Radiology, Addenbrooke's Hospital NHS Trust, Cambridge, England (P.B., R.S.). Received May 24, 2006; revision requested July 27; revision received October 20; accepted November 21; final version accepted April 2, 2007. Address correspondence to C.J.C.C. (e-mail: cjcc2{at}ukonline.co.uk).
Formal ethical approval was granted by the local research ethics committee; all participants gave written consent. The purpose of the study was to prospectively evaluate the feasibility of a noninvasive method of breast tumor localization in 25 participants, based on the coregistration of three-dimensional (3D) ultrasonographic (US) data with surface contour data obtained by using a 3D laser camera. The tumor is segmented from the US data, and a surface-rendered 3D image of the tumor, in relation to the breast surface contour, is produced. From a personal computer in the operating room, the surgeon can dynamically view a 3D image of the tumor within the breast. This noninvasive method was equivalent to conventional techniques in 18 of 25 patients but was less successful in larger-breasted patients. In selected patients, this localization method could provide an alternative to conventional invasive techniques and can offer both spatial localization and tumor morphology.
© RSNA, 2007